載入...

Potential role of daratumumab in the treatment of multiple myeloma

Multiple myeloma is the second most common hematologic malignancy in the US. Treatments utilizing alkylating agents, corticosteroids, proteasome inhibitors, and immunomodulatory drugs have resulted in significant survival benefits, however, despite the advances, relapse is inevitable. Decreased dept...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Khagi, Yulian, Mark, Tomer M
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069139/
https://ncbi.nlm.nih.gov/pubmed/24971019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S49480
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!